2023-09-07 00:03:00
Every third man over the age of 15 is a carrier of at least one type of genital human papillomavirus (HPV). This is evidenced by the data of a large-scale meta-study published in the September issue of the medical journal The Lancet Global Health.
Scientists led by Dr. Lai Bruni from the Cancer Institute of Catalonia combined data from 65 studies conducted from 1995 to 2022 to compile an epidemiological picture of the prevalence of HPV among men on a global scale. As it turned out, 31% of men are carriers of the virus, and 21% are infected with one or more of the especially dangerous HPV serotypes that cause cancer. In North America and Sub-Saharan Africa, these rates were highest (on average 45% and 37% of HPV carriers, respectively), and lowest in East and Southeast Asia (15% of HPV carriers).
“This global study of the prevalence of genital papillomavirus infection among men confirms how widespread the problem is. high HPV infection [канцерогенного] risk can cause genital warts, cancer of the oral cavity, penis and anus in men. We must continue to look for opportunities to prevent human papillomavirus infection and reduce the incidence of HPV-related diseases in both men and women,” said Meg Doherty.
The WHO emphasizes that most infected people do not have any symptoms, but in the long term, infection can lead to serious health problems. In women, infection with certain HPV serotypes causes cervical cancer, which usually appears decades after infection. More than 340,000 women die each year from HPV-associated cervical cancer. Other serotypes of the virus can cause the formation of anogenital warts (warts).
WHO recommends the large-scale introduction of HPV vaccines to prevent cancers caused by the virus, especially cervical cancer. First of all, the organization recommends vaccinating girls aged 9-14 years, the second most important target group is older girls and women, as well as men, cites TASS excerpts.
1694049262
#man #world #infected #HPV